Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

34,558

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

34,558 results for “therapy”

Learn how ShareScore rates datasets ↗
zenodo36/100

Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson's disease

<p><strong>Abstract: </strong>We address an unmet challenge in Parkinson&rsquo;s disease: the lack of biomarkers to identify the right patients for the right therapy, which is a main reason clinical trials for disease modifying treatments have all failed. The gut microbiome is a new target for treatment of neurodegenerative diseases. Our aim was to develop microbiome-based biomarkers to guide patient selection for microbiome-based clinical trials. We used microbial taxa that are robustly associated with PD across studies and at high significance as dysbiotic features of PD. &nbsp;Using individual-level taxonomic relative abundance data, we classified patients according to their dysbiotic features, effectively defining microbiome-based subtypes of PD. &nbsp;We show that not all persons with PD have a dysbiotic microbiome, and not all dysbiotic PD microbiomes have the same features. Grounded in robust and reproducible data from differential abundance studies, we propose an intuitive and easily modifiable method to identify the optimal candidates for microbiome-based clinical trials, and subsequently, for treatments that are personalized for each individual&rsquo;s dysbiotic features. We demonstrate the method for PD. The concept, and the method, is generalizable for any disease with a microbiome component.</p> <p><strong>Zenodo</strong>&nbsp;<strong>content: </strong>In this Zenodo archive we provide (a) the method described step by step, which can be implemented in Microsoft Excel (we used v.16.84 (RRID:SCR_016137)&nbsp;<a href="https://www.microsoft.com/en-gb/">https://www.microsoft.com/en-gb/</a>) or in R (we used v4.3.3 (RRID:SCR_001905) <a title="https://www.r-project.org/ Cmd+Click or tap to follow the link" href="https://www.r-project.org/">https://www.r-project.org/</a>); and&nbsp;(b) data used to generate the results, tables and figures (except figure 2). Data for creating figure 2 can be found in source data&nbsp;(doi: 10.5281/zenodo.7246185) and the method is described by Wallen et al 2022&nbsp;(DOI:&nbsp;<u><a href="https://doi.org/10.1038/s41467-022-34667-x" target="_blank" rel="noopener">10.1038/s41467-022-34667-x</a></u>). All data used here were extracted from the original source data reported by<strong> </strong>Wallen et. al. 2022 (DOI:&nbsp;<u><a href="https://doi.org/10.1038/s41467-022-34667-x" target="_blank" rel="noopener">10.1038/s41467-022-34667-x</a></u>) which can be found on Zenodo (DOI: 10.5281/zenodo.7246185).</p>

opencc-by-4.0May 2024View details →
zenodo36/100

Isoniazid Preventive Therapy (IPT) uptake and Tuberculin Skin Test (TST) uptake among adults receiving primary HIV care in South Africa .

<p>We aimed to evaluate Isoniazid Preventive Therapy&nbsp;(IPT) and tuberculin skin testing (TST) uptake under primary care clinic conditions, and determine health care worker (HCW) fidelity to the 2014&nbsp;South African IPT guidelines.&nbsp;Following training on IPT guidelines and tuberculin skin testing (TST), 3&nbsp;primary care clinics identified their IPT implementation strategy in a participatory manner.&nbsp;Using routine register data, TST uptake was determined 3 months before and 5 months after the intervention.&nbsp;Records were reviewed to identify IPT/TST uptake and factors associated with IPT initiation among adults living with HIV.</p>

opencc-by-4.0Dec 2017View details →
zenodo36/100

What evidence exists for myofunctional therapy with prefabricated appliances? A systematic review with meta-analyses of randomized trials

<p>Dataset for all analysis in the review</p>

opencc-by-4.0Dec 2018View details →
zenodo36/100

Supplementary Materials for: A Comprehensive Cohort Analysis Comparing Growth and GH Therapy Response in IGF1R Mutation Carriers and SGA Children

<p>Supplemental Tables and Figures for the clinical research article:&nbsp;<strong>A Comprehensive Cohort Analysis Comparing Growth and GH Therapy Response in IGF1R Mutation Carriers and SGA Children</strong></p>

opencc-by-4.0May 2019View details →
zenodo36/100

Supplementary file 23 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 22 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 21 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 19 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 17 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 18 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 16 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 15 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 2 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 10 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 3 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 5 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 14 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 4 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 13 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →
zenodo36/100

Supplementary file 9 for the Cochrane review Psychological therapies for people with borderline personality disorder

<p>A Trial Sequential Analysis figure</p>

opencc-by-4.0Oct 2019View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.